These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33081033)

  • 41. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
    Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
    Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
    Li G; Yang M; Zuo L; Wang MX
    Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
    Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
    Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer.
    Su F; Zhu S; Ruan J; Muftuoglu Y; Zhang L; Yuan Q
    Oncotarget; 2016 Jan; 7(4):4142-54. PubMed ID: 26716652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation.
    Lee YC; Wang WL; Chang WC; Huang YH; Hong GC; Wang HL; Chou YH; Tseng HC; Lee HT; Li ST; Chen HL; Wu CC; Yang HF; Wang BY; Chang WW
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells.
    Bolis M; Paroni G; Fratelli M; Vallerga A; Guarrera L; Zanetti A; Kurosaki M; Garattini SK; Gianni' M; Lupi M; Pattini L; Barzago MM; Terao M; Garattini E
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32384653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.
    Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of Notch1 inhibits medial edge epithelium apoptosis in all-trans retinoic acid-induced cleft palate in mice.
    Zhang Y; Dong S; Wang W; Wang J; Wang M; Chen M; Hou J; Huang H
    Biochem Biophys Res Commun; 2016 Aug; 477(3):322-8. PubMed ID: 27343556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
    Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
    Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells.
    Schedlich LJ; O'Han MK; Leong GM; Baxter RC
    Biochem Biophys Res Commun; 2004 Jan; 314(1):83-8. PubMed ID: 14715249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A truncated-Flt1 isoform of breast cancer cells is upregulated by Notch and downregulated by retinoic acid.
    Mezquita B; Mezquita J; Barrot C; Carvajal S; Pau M; Mezquita P; Mezquita C
    J Cell Biochem; 2014 Jan; 115(1):52-61. PubMed ID: 23904188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase Calpha expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells.
    Cho Y; Talmage DA
    Exp Cell Res; 2001 Sep; 269(1):97-108. PubMed ID: 11525643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic Effect of Retinoic Acid Polymeric Micelles and Prodrug for the Pharmacodynamic Evaluation of Tumor Suppression.
    Zhu YH; Ye N; Tang XF; Khan MI; Liu HL; Shi N; Hang LF
    Front Pharmacol; 2019; 10():447. PubMed ID: 31156425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells.
    Siwak DR; Mendoza-Gamboa E; Tari AM
    Int J Oncol; 2003 Dec; 23(6):1739-45. PubMed ID: 14612949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
    Noblejas-López MDM; Nieto-Jimenez C; Burgos M; Gómez-Juárez M; Montero JC; Esparís-Ogando A; Pandiella A; Galán-Moya EM; Ocaña A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):383. PubMed ID: 31470872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinoic Acid Facilitates Toll-Like Receptor 4 Expression to Improve Intestinal Barrier Function through Retinoic Acid Receptor Beta.
    Li Y; Gao Y; Cui T; Yang T; Liu L; Li T; Chen J
    Cell Physiol Biochem; 2017; 42(4):1390-1406. PubMed ID: 28715808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.